UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

Journal of thrombosis and haemostasis, 2005-04, Vol.3 (4), p.640-648

2005

Volltextzugriff (PDF)

The effect of fibrinogen concentrate on thrombocytopenia

Journal of thrombosis and haemostasis, 2007-05, Vol.5 (5), p.1019-1025

2007

Volltextzugriff (PDF)

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.691-697

2013

Volltextzugriff (PDF)

Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-11, Vol.21 (6), p.784-790

2015

Volltextzugriff (PDF)

Treatment of traumatic bleeding with recombinant factor VIIa

The Lancet (British edition), 1999-11, Vol.354 (9193), p.1879-1879

1999

Volltextzugriff (PDF)

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

Journal of thrombosis and haemostasis, 2003-03, Vol.1 (3), p.450-455

2003

Volltextzugriff (PDF)

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

Stroke (1970), 2000-06, Vol.31 (6), p.1283-1288

2000

Volltextzugriff (PDF)

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-01, Vol.20 (1), p.e15-e22

2014

Volltextzugriff (PDF)

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-07, Vol.15 (4), p.904-910

2009

Volltextzugriff (PDF)

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.854-859

2011

Volltextzugriff (PDF)

Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor

International journal of laboratory hematology, 2015-08, Vol.37 (4), p.521-529

2015

Volltextzugriff (PDF)

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.782-789

2013

Volltextzugriff (PDF)

Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery

British journal of haematology, 2000-09, Vol.110 (3), p.715-720

2000

Volltextzugriff (PDF)

Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2202-2209

2015

Volltextzugriff (PDF)

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (4), p.782-786

2008

Volltextzugriff (PDF)

Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial

Thrombosis and haemostasis, 2010-02, Vol.103 (2), p.351-359

2010

Volltextzugriff (PDF)

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.625-629

2011

Volltextzugriff (PDF)

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI

Journal of thrombosis and haemostasis, 2006-01, Vol.4 (1), p.192-200

2006

Volltextzugriff (PDF)

450 THE NATURAL HISTORY OF HEPATITIS C-INFECTED HEMOPHILIA PATIENTS – DOES TREATMENT MATTER?

Journal of hepatology, 2011-03, Vol.54, p.S183-S183

2011

Volltextzugriff (PDF)

Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding

International journal of oral and maxillofacial surgery, 2001-12, Vol.30 (6), p.518-521

2001

Volltextzugriff (PDF)

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-09, Vol.15 (5), p.1065-1073

2009

Volltextzugriff (PDF)

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-11, Vol.18 (6), p.881-887

2012

Volltextzugriff (PDF)

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.676-685

2009

Volltextzugriff (PDF)

Physical activity participation and bleeding characteristics in young patients with severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.695-700

2009

Volltextzugriff (PDF)

Continuous infusion of coagulation factors

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-05, Vol.8 (3), p.170-177

2002

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Englisch
(259)
Hebräisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

The effect of fibrinogen concentrate on thrombocytopenia

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

Treatment of traumatic bleeding with recombinant factor VIIa

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study

Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery

Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI

450 THE NATURAL HISTORY OF HEPATITIS C-INFECTED HEMOPHILIA PATIENTS – DOES TREATMENT MATTER?

Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

Physical activity participation and bleeding characteristics in young patients with severe haemophilia

Continuous infusion of coagulation factors

Suchergebnisse filtern